Search

Author/Creator Inagaki, Hitoshi

1. Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trial. (June 2020)

Authors:
Nishikawa, Kazuhiro; Murotani, Kenta; Fujitani, Kazumasa; Inagaki, Hitoshi; Akamaru, Yusuke; Tokunaga, Shinya; Takagi, Masakazu; Tamura, Shigeyuki; Sugimoto, Naotoshi; Shigematsu, Tadashi; Yoshikawa, Takaki; Ishiguro, Tohru; Nakamura, Masato; Hasegawa, Hiroko; Morita, Satoshi; Miyashita, Yumi; Ts...
Journal:
European journal of cancer
Issue:
Volume 132(2020)
Page Start:
159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial. Issue 7 (May 2015)

Authors:
Nishikawa, Kazuhiro; Fujitani, Kazumasa; Inagaki, Hitoshi; Akamaru, Yusuke; Tokunaga, Shinya; Takagi, Masakazu; Tamura, Shigeyuki; Sugimoto, Naotoshi; Shigematsu, Tadashi; Yoshikawa, Takaki; Ishiguro, Tohru; Nakamura, Masato; Morita, Satoshi; Miyashita, Yumi; Tsuburaya, Akira; Sakamoto, Junichi; ...
Journal:
European journal of cancer
Issue:
Volume 51:Issue 7(2015:May)
Page Start:
808
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search